FDA Greenlights Imaging Agent to Detect Residual Cancer After Lumpectomy

Pegulicianine used with an approved imaging system achieved overall diagnostic accuracy of 84%

Related Keywords

California ,United States ,Stanford University ,Boston ,Massachusetts ,Barbara Smith ,Charles Bankhead ,Irene Wapnir ,Stanford University Medical Center , ,Lumicell Direct Visualization System ,Mass General Brigham ,Medpage Today ,